From L. Zhang et al., “Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors,” Science, doi:10.1126/science.abb3405, 2020.
Workflow: 
Published

Turning Research into Practice (TRIP Database)